TickerFactsScreenerDevelopers

Crinetics Pharmaceuticals, Inc. (CRNX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$5.47M2017: -$9.48M2018: -$19.46M2019: -$46.38M2020: -$62.03M2021: -$88.59M2022: -$115.20M2023: -$168.60M2024: -$230.19M2025: -$377.92M-$377.92M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$377.92M-64.2%
2024-$230.19M-36.5%
2023-$168.60M-46.3%
2022-$115.20M-30.0%
2021-$88.59M-42.8%
2020-$62.03M-33.7%
2019-$46.38M-138.4%
2018-$19.46M-105.3%
2017-$9.48M-73.4%
2016-$5.47M—